MDS

A survivor shares how hearing loss and cancer deepened her grief, leading her to confront denial and embrace support from her church community.

The FDA granted orphan drug designation to the investigational therapy MNV-201 for myelodysplastic syndrome, a serious, age-related blood disorder.

As a 12-year survivor of myelodysplastic syndrome, I’ve learned that each of us faces cancer our own way, and in the end, we can say we lived life our way.

Learn how myelodysplastic syndrome treatment has advanced with targeted therapies and anemia management while balancing quality of life for patients.

The U.S. FDA has granted fast track designation to the investigational therapy MNV-201 for the treatment of myelodysplastic syndrome.

A cancer survivor explains that we must all become involved in trying to bring back cancer research.

Results from the phase 3 VERONA trial were presented at the 2025 Society of Hematologic Oncology Annual Meeting.

In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, female and non-White patients.

I never would have survived through 15 years of cancer without my two passions: faith and writing.

Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, joy and reasons to keep going.

I describe what it is like to have an “invisible” cancer.

As a cancer survivor I explain the importance of looking forward to life.

After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory higher-risk myelodysplastic syndrome.

In an upside-down, topsy-turvy world, cancer can be a distraction for us.

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.

As a cancer survivor, I talk about where to look for the light when in utter darkness.

As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.

I have been frustrated lately by my increasing slowness following an blood cancer diagnosis, which has become noticeable to others.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with myelodysplastic syndrome.

After a long and difficult journey, I finally published the book I set out to write as my legacy, overcoming cancer and the challenges of deafness.

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT.

As a survivor of MDS, I’ve learned to make the best of every day and to be thankful for life. Sometimes this means avoiding others who are less grateful.